Depression of lymphocyte responses after surgical trauma.

PubWeight™: 1.29‹?› | Rank: Top 10%

🔗 View Article (PMC 2072621)

Published in Br J Exp Pathol on December 01, 1973

Authors

M C Berenbaum, P A Fluck, N P Hurst

Articles cited by this

The effects of surgery on the blood levels and metabolism of 17-hydroxycorticosteroids in man. J Clin Invest (1954) 2.91

Postoperative depression of the lymphocyte response to phytohaemagglutinin. Lancet (1967) 2.57

Immunosuppressive effect of surgery. Lancet (1971) 2.44

Alterations of the immune response following severe thermal injury. Arch Surg (1966) 2.03

Corticosteroid treatment and surgery. 1. An investigation of the indications for steroid cover. Anaesthesia (1969) 2.00

Thymus-derived lymphocytes sequestered in the bone marrow of hydrocortisone-treated mice. J Immunol (1972) 1.94

Postoperative depression of tumour-directed cell-mediated immunity in patients with malignant disease. Br Med J (1972) 1.84

ALTERED REACTIVITY OF SKIN HOMOGRAFTS IN SEVERE THERMAL INJURY. Ann Surg (1964) 1.71

Delayed hypersensitivity status of burned patients. Surg Forum (1966) 1.33

Suppression of experimental allergic encephalomyelitis by stress. Proc Soc Exp Biol Med (1962) 1.33

Cell-mediated immunity after thermal injury. Ann Surg (1973) 1.24

The effects of surgery and anesthesia on the immunologic responsiveness of the rat. Surgery (1969) 1.18

Stress and antibody response in rats. Int Arch Allergy Appl Immunol (1969) 1.10

Disturbed immune reactions following surgery. Br J Surg (1967) 1.06

Hormonal regulation of the immune response. II. Influence of pituitary and adrenal activity on immune responsiveness in vitro. Cell Immunol (1971) 1.01

Cell-mediated immunity in patients with malignant melanoma. Br J Dermatol (1972) 0.99

The effect of single large dose hydrocortisone treatment on IgM and IgG antibody production, morphological distribution of antibody producing cells and immunological memory. Immunology (1971) 0.99

Hormonal regulation of the immune response. I. Induction of an immune response in vitro with lymphoid cells from mice exposed to acute systemic stress. Cell Immunol (1971) 0.95

Effect of stress on skin transplantation immunity in mice. Science (1960) 0.94

Changes in granulopoiesis in the rat associated with prolonged halothane anesthesia. Anesthesiology (1967) 0.92

Plasma levels of ACTH and cortisol in man during diethyl ether anesthesia and surgery. Anesthesiology (1968) 0.87

Pituitary-adrenal response to surgical stress in patients receiving corticotrophin treatment. Lancet (1970) 0.87

Effects of surgery on plasma levels of cortisol, corticosterone and non-protein-bound-cortisol. Acta Endocrinol (Copenh) (1970) 0.86

Effects of compounds which inhibit lymphocyte stimulation on the utilization of glucose by leukocytes. J Allergy (1970) 0.86

Lymphocyte response to phytohaemagglutinin following cholecystectomy. Acta Pathol Microbiol Scand (1969) 0.85

Effect of halothane anesthesia on experimental Salmonella peritonitis in mice. J Surg Res (1967) 0.84

Endocrine responses to anaesthetic agents. Br J Anaesth (1973) 0.84

Effect of anesthesia on immunity. J Surg Res (1967) 0.84

Immunosuppressive effect of surgery. Lancet (1971) 0.79

Articles by these authors

(truncated to the top 100)

A method for testing for synergy with any number of agents. J Infect Dis (1978) 9.52

Is azathioprine a better immunosuppressive than 6-mercaptopurine? Clin Exp Immunol (1971) 3.47

Synergy, additivism and antagonism in immunosuppression. A critical review. Clin Exp Immunol (1977) 2.89

Postoperative depression of the lymphocyte response to phytohaemagglutinin. Lancet (1967) 2.57

Criteria for analyzing interactions between biologically active agents. Adv Cancer Res (1981) 2.49

The expected effect of a combination of agents: the general solution. J Theor Biol (1985) 2.06

Non-secretion of ABO blood group antigens as a host susceptibility factor in the spondyloarthropathies. Br Med J (Clin Res Ed) (1987) 1.91

In vivo biological activity of the components of haematoporphyrin derivative. Br J Cancer (1982) 1.82

Bronchodilatation after inhalation of the antihistamine clemastine. Thorax (1978) 1.76

Association of long lasting unsurmountable histamine H2 blockade and gastric carcinoid tumours in the rat. Gut (1985) 1.58

Photodynamic destruction of human bladder carcinoma. Br J Cancer (1975) 1.55

Cerebral photosensitisation by haematoporphyrin derivative. Evidence for an endothelial site of action. Br J Cancer (1986) 1.53

Time-dependent immunosuppressive effects of anti-thymocyte serum. Nature (1967) 1.48

meso-Tetra(hydroxyphenyl)porphyrins, a new class of potent tumour photosensitisers with favourable selectivity. Br J Cancer (1986) 1.47

Dose-response curves for agents that impair cell reproductive integrity. A fundamental difference between dose-response curves of antimetabolites and those for radiation and alkylating agents. Br J Cancer (1969) 1.44

Health economics as an aspect of health outcome: basic principles and application in rheumatoid arthritis. Br J Rheumatol (1995) 1.43

Photodynamic therapy with chlorins for diffuse malignant mesothelioma: initial clinical results. Br J Cancer (1991) 1.42

Measuring health status in British patients with rheumatoid arthritis: reliability, validity and responsiveness of the short form 36-item health survey (SF-36). Br J Rheumatol (1998) 1.38

Cardiac and pulmonary effects of high doses of cyclophosphamide and isophosphamide. Cancer Res (1974) 1.36

Is day care equivalent to inpatient care for active rheumatoid arthritis? Randomised controlled clinical and economic evaluation. BMJ (1998) 1.35

Correlations between methods for measurement of synergy. J Infect Dis (1980) 1.29

The growth of human tumours in immunosuppressed mice and their response to chemotherapy. Br J Cancer (1974) 1.27

In vivo determination of the fractional kill of human tumor cells by chemotherapeutic agents. Cancer Chemother Rep (1972) 1.26

Cell respiration as a requirement for antibody release in vitro. Nature (1968) 1.21

Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumour photosensitizers. Biochem J (1989) 1.19

Synergistic effect of cortisol and prostaglandin E2 on the PHA response. Relation to immunosuppression induced by trauma. Clin Exp Immunol (1976) 1.11

Translocation of protein kinase C to a Triton-insoluble sub-cellular compartment induced by the lipophilic gold compound auranofin. Biochem Pharmacol (1988) 1.06

The therapeutic significance of the dose response curve for antilymphocytic serum. Transplantation (1971) 1.02

Uptake of chloroquine and hydroxychloroquine by human blood leucocytes in vitro: relation to cellular concentrations during antirheumatic therapy. Ann Rheum Dis (1987) 1.02

The effect of microsomal enzyme inhibition on the immunosuppressive and toxic effects of cyclophosphamide. Clin Exp Immunol (1973) 1.01

Modulation by phorbol myristate acetate of arachidonic acid release and leukotriene synthesis by human polymorphonuclear leukocytes stimulated with A23187. Biochem Biophys Res Commun (1986) 1.00

Immunosuppression by L-asparaginase. Nature (1970) 0.99

Zinc increases phorbol ester receptors in intact B-cells, neutrophil polymorphs and platelets. FEBS Lett (1989) 0.98

The relation between the physico-chemical properties and immunosuppressive effects of an homologous series of sulphonic acid esters. Immunology (1967) 0.97

Molecular basis of activation and regulation of the phagocyte respiratory burst. Ann Rheum Dis (1987) 0.96

The sensitivity to chemotherapeutic agents of a rat tumour grown in immunosuppressed mice. Br J Cancer (1971) 0.95

Effects of L-asparaginase on lymphocyte-target cell reactions in vitro. Nature (1970) 0.95

Synergy with double and triple antibiotic combinations compared. J Antimicrob Chemother (1983) 0.95

Evidence for defect of complement-mediated phagocytosis by monocytes from patients with rheumatoid arthritis and cutaneous vasculitis. Br Med J (Clin Res Ed) (1981) 0.94

Wavelength and light-dose dependence in tumour phototherapy with haematoporphyrin derivative. Br J Cancer (1985) 0.94

Immunosuppressive agents: the design of selective therapeutic schedules. Antibiot Chemother (1969) 0.93

Coxsackie B infection and arthritis. Br Med J (Clin Res Ed) (1983) 0.93

Is chronic renal failure a risk factor for the development of erosive osteoarthritis? Ann Rheum Dis (1989) 0.93

Differential effects of mepacrine, chloroquine and hydroxychloroquine on superoxide anion generation, phospholipid methylation and arachidonic acid release by human blood monocytes. Biochem Pharmacol (1986) 0.92

The rabbit VX2 tumour as a model for carcinomas of the tongue and larynx. Acta Otolaryngol (1989) 0.91

Synergy assessment with growth curves. J Infect Dis (1984) 0.90

Radiosensitivity of immunologically activated cells. Nature (1966) 0.89

Minor synergy and antagonism may be clinically important. J Antimicrob Chemother (1987) 0.88

HPD - a study of its components and their properties. Adv Exp Med Biol (1983) 0.87

Selective suppression of murine antibody-dependent cell-mediated cytotoxicity by azathioprine. Transplantation (1975) 0.87

A pilot study of the economic cost and clinical outcome of day patient vs inpatient management of active rheumatoid arthritis. Br J Rheumatol (1994) 0.86

Functional defects of monocyte C3b receptor-mediated phagocytosis in rheumatoid arthritis (RA): evidence for an association with the appearance of a circulating population of non-specific esterase-negative mononuclear phagocytes. Ann Rheum Dis (1983) 0.85

Wegener's granulomatosis complicated by diabetes insipidus. Ann Rheum Dis (1983) 0.84

Evidence for intrinsic cellular defects of 'complement' receptor-mediated phagocytosis in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol (1984) 0.84

Studies of the effect of D-penicillamine and sodium aurothiomalate therapy on superoxide anion production by monocytes from patients with rheumatoid arthritis: evidence for in vivo stimulation of monocytes. Ann Rheum Dis (1986) 0.84

The localization of haemolytic antibody in sections of lymphoid organs: an improved method. Immunology (1970) 0.84

Synergy and antagonism are not synonymous with therapeutic advantage and disadvantage. J Antimicrob Chemother (1988) 0.84

Role of mitosis and mitotic inhibition in the immunosuppressive action of thioguanine. Nature (1966) 0.83

Inhibition of epidermal growth factor binding to HeLa cells by auranofin. Biochem Pharmacol (1987) 0.83

Calcium ionophore A23187 enhances human neutrophil superoxide release, stimulated by phorbol dibutyrate, by converting phorbol ester receptors from a low- to high-affinity state. FEBS Lett (1987) 0.83

Consequences of synergy between environmental carcinogens. Environ Res (1985) 0.82

Protective effects of a novel perfluorochemical emulsion in photodynamic therapy. Biomater Artif Cells Immobilization Biotechnol (1992) 0.82

The effect of cysteine on the immunosuppressive activity of busulphan, cyclophosphamide and nitrogen mustard. Br J Cancer (1971) 0.82

Time-dependence and selectivity of immunosuppressive agents. Immunology (1979) 0.82

Medically unexplained symptoms in patients referred to a specialist rheumatology service: prevalence and associations. Rheumatology (Oxford) (2003) 0.82

Quantifying the burden of emotional ill-health amongst patients referred to a specialist rheumatology service. Rheumatology (Oxford) (2003) 0.81

Transplantation and immunosuppression. Mod Trends Immunol (1967) 0.81

An audit of methotrexate and folic acid for rheumatoid arthritis. Experience from a teaching centre. Br J Rheumatol (1995) 0.81

Effect of some metabolic inhibitors on plaque formation in Jerne plates. Nature (1967) 0.81

Monocyte superoxide anion production in rheumatoid arthritis: preliminary evidence for enhanced rates of superoxide anion production by monocytes from patients receiving penicillamine, sodium aurothiomalate and corticosteroids. Ann Rheum Dis (1984) 0.81

Effect of cyclophosphamide on the homograft response in the guinea pig. Transplantation (1965) 0.81

Auranofin stimulates LTA hydrolase and inhibits 5-lipoxygenase/LTA synthase activity of isolated human neutrophils. Biochem Pharmacol (1990) 0.81

Cervical spine surgery in patients with rheumatoid arthritis: an appraisal. Ann Rheum Dis (1996) 0.81

Re: W. R. Greco et al., Application of a new approach for the quantitation of drug synergism to the combination of cis-diamminedichloroplatinum and 1-beta-D-arabinofuranosylcytosine. Cancer Res., 50: 5318-5327, 1990. Cancer Res (1992) 0.81

IgG (kappa) paraproteinaemia and arthritis. Br J Rheumatol (1987) 0.80

Differential asparaginase sensitivity of T-cell and B-cell responses. Clin Exp Immunol (1973) 0.80

The mode of action of cytotoxic drugs. Proc R Soc Med (1970) 0.80

An evaluation of the Health Assessment Questionnaire (HAQ) in a long-term longitudinal follow-up of disability in rheumatoid arthritis. Br J Rheumatol (1994) 0.80

Porphyrin sensitizers in tumour phototherapy. Novel sensitizers of the chlorin and bacteriochlorin class with amphiphilic properties. J Photochem Photobiol B (1990) 0.79

Effects of piroxicam on superoxide generation, phospholipid methylation and leukotriene production by human blood mononuclear cells. J Rheumatol (1987) 0.78

Enhancement of protein kinase C-mediated EGF receptor phosphorylation by auranofin. Scand J Rheumatol (1988) 0.78

Letter: Predicting response of human cancer to chemotherapy. Lancet (1974) 0.78

Inhibition of protein kinase C activity by the antirheumatic drug auranofin. Biochem Pharmacol (1989) 0.78

Transient presence in serum of an atypical alkaline phosphatase. Clin Chim Acta (1976) 0.78

Immunosuppressive agents: generation and consequences of differing dose-response curves. Proc R Soc Med (1972) 0.78

Research ethics and deception. Lancet (1980) 0.78

Premature development of erosive osteoarthritis of hands in patients with chronic renal failure. Ann Rheum Dis (1990) 0.77

Neutrophil function during chemotherapy for Hodgkin's disease. Br J Cancer (1981) 0.77

Photodynamic therapy of a mouse glioma: intracranial tumours are resistant while subcutaneous tumours are sensitive. Br J Cancer (1991) 0.77

Re: Quality of life measures. Br J Rheumatol (1997) 0.77

Sjögren's syndrome, vasculitis, and cryoglobulinaemia associated with a monoclonal IgM (kappa) paraprotein with rheumatoid factor activity. Ann Rheum Dis (1987) 0.77

Immunosuppression by platinum diamines. Br J Cancer (1971) 0.77

Intercellular immunological controls and modulation of cyclic AMP levels. Some doubts. Immunology (1976) 0.77

Reactive arthritis--infectious agents and genetic susceptibility in the pathogenesis of sero-negative arthritis. Scott Med J (1983) 0.76

Does economic evaluation have anything to offer the rheumatologist? Rheumatology (Oxford) (1999) 0.76

Auranofin increases the affinity of phorbol dibutyrate receptors in chronic lymphocytic leukemia cells (B cells). J Immunol (1987) 0.76

Concepts for describing the interaction of two agents. Radiat Res (1991) 0.75

Dose-response curves for agents that impair cell reproductive integrity. The relation between dose-response curves and the design of selective regimens in cancer chemotherapy. Br J Cancer (1969) 0.75

Increased therapeutic efficiency of a lipid-soluble alkylating agent incorporated in liposomes. Br J Cancer (1982) 0.75

Screening for antimalarial maculopathy in rheumatology clinics. Br Med J (Clin Res Ed) (1985) 0.75